- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02474979
Reduced Pressure for Less Pressure Ulcers
Reduced Pressure for Less Pressure Ulcers. Effect of the CBPM-system in a Swedish University Hospital
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background The first national PU prevalence study in Sweden conducted in 2011 showed a prevalence of 16.6% (n=16 466) in hospital settings. High age and reduced mobility/activity are main risk factors. International evidence-based guidelines for prevention of PU are available. Pressure relief (e.g repositioning, mattresses, chair cushions, heel cushions) is the main stay of preventive measures. Recent research shows that PU prevention is not a high priority. For example, the corner stone of prevention, repositioning, is not conducted for risk patients.
Aim To evaluate the effect of the CBPM-system on the prevalence and incidence of PU in hospital setting
Method Design: A randomised controlled trial will be conducted Sample: All patients admitted to the geriatric unit. Intervention: The CBPM-system will be used from admittance to discharge (not more than 14 days). Standard PU prevention (PU reducing mattress, floating heels, repositioning) Control group: Standard PU prevention (PU reducing mattress, floating heels, repositioning) Randomisation: Sealed envelopes will be used. Procedure: Two study nurses are responsible for inclusion of patients and data collection on day 1,3,7 and discharge. A photo will be taken of any PU. A PU expert will assess the photos after completed data collection (PU category 1-4). She will be blinded to group allocation.
Power calculation: The primary outcome of interest is the PU prevalence. Previous point prevalence studies in this geriatric unit shows a prevalence of 45%. The investigators goal is that the CBPM-system results in 20% decrease in the PU prevalence. In order to have 80% power to detect such a decrease with a two-sided two-sample proportions test at the 5% level, 89 patients per treatment group is needed. Intention-to-treat principals will be used.
Discussion The prevalence of PU, as well as prevention to risk patients are quality indicators in health care. National studies reveal an urgent need for quality improvement, New nursing methods and equipment must be systematically and scientifically evaluated.The results of this study will be valuable for nursing education and in international and national patient safety work to prevent PU. The results will also be valuable for other health professionals (physicians, physical and occupational therapists).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Uppland
-
Uppsala, Uppland, Sweden, 75125
- Akademiska sjukhuset
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Admitted to geriatric unit 30A during Sunday after 4 pm to Friday until 4 pm
Exclusion Criteria:
- Expected to be discharged before data collection in day 3
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CBPM-system
CBPM-system (Continuous Bedside Pressure Mapping System): the bed is equipped with a pressure sensing mat including thousands of sensors.
It is connected with a monitor that continuously registers the pressure between the body and the bed surface (interface pressure).
The pressure is indicated by colors, where warmer colors indicate higher pressure.
The CBPM-system will be used in addition to standard pressure ulcer prevention (PU reducing mattress, floating heels, repositioning).
|
The bed is equipped with a pressure sensing mat including thousands of sensors.
It is connected with a monitor that continuously registers the pressure between the body and the bed surface (interface pressure).
The pressure is indicated by colors, where warmer colors indicate higher pressure.
|
|
Experimental: Control
Standard pressure ulcer prevention (PU reducing mattress, floating heels, repositioning).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PU prevalence (Category 1-4) - change from baseline
Time Frame: admission to discharge or last assessment at 14 days
|
The most severe PU for each patient is included in the calculation
|
admission to discharge or last assessment at 14 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of PU per category and patient
Time Frame: admission to discharge or last assessment at 14 days
|
Category 1-4
|
admission to discharge or last assessment at 14 days
|
|
Number of preventive interventions
Time Frame: admission to discharge or last assessment at 14 days
|
pressure reducing mattress, heel cushions, repositioning, repositioning aid, preventive dressing
|
admission to discharge or last assessment at 14 days
|
|
Patient´s experience of comfort in bed
Time Frame: admission to discharge or last assessment at 14 days
|
Visual Analog Scale 1-10
|
admission to discharge or last assessment at 14 days
|
|
Peak pressure
Time Frame: admission to discharge or last assessment at 14 days
|
mmHg (mean)
|
admission to discharge or last assessment at 14 days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lena Gunningberg, Professor, Uppsala University, Uppsala, Sweden
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EPN2014/529
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcer
-
McMaster UniversityQueen's University; Kindera Living; Room 217 FoundationNot yet recruitingPressure Injury | Pressure Injuries | Pressure Ulcer (PU)Canada
-
King Abdullah Medical CityRecruitingPressure Injury | Pressure Ulcer, Buttock | Pressure Injury Stage 2 | Pressure Ulcers Stage II | BedsoreSaudi Arabia
-
Fundación para el Fomento de la Investigación Sanitaria...Not yet recruitingPressure Ulcers | Biofilm | Biofilm Formation | Pressure Ulcers Stage III | Pressure Ulcer ( Stage 2-3) | Pressure Ulcer Prevention | Biofilm Removal
-
Applied Biologics, LLCSerenaGroup, Inc.RecruitingPressure Ulcer | Pressure Area | Ulcer, Pressure | Pressure WoundUnited States
-
Nottingham University Hospitals NHS TrustUniversity of Leicester; University of SurreyRecruitingPressure Injuries | Pressure Ulcers, Bedsores, Decubitus UlcerUnited Kingdom
-
Bartın UnıversityCompletedPressure Ulcer Prevention | Pressure Ulcer Prevention Training for Home Care PatientsTurkey (Türkiye)
-
The Cleveland ClinicSuspendedStage 1 Pressure Ulcer | Stage 2 Pressure UlcerUnited States, Austria
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedPressure Injuries | Medical Device Related Pressure Ulcer (MDRPU)Turkey (Türkiye)
-
Ruijin HospitalEnrolling by invitationPressure Ulcer PreventionChina
-
Ankara Medipol UniversityDr. Lutfi Kirdar Kartal Training and Research Hospital; Fenerbahce UniversityNot yet recruitingPressure Ulcer (PU)
Clinical Trials on Control
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationCritical Illness | Respiratory Failure | Mechanical VentilationUnited States
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryRecruitingIschemic Stroke, AcuteCanada, Australia
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Takeshi MorimotoUniversity of the RyukyusCompletedCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted